| Geriatric Medicine Jaspreet.Bhangu@sjhc.london.on.ca |
|||
 JASPREET BHANGU MD, FRCP(C), Assistant Professor Dr. Jaspreet Bhangu joined the Division of Geriatric Medicine as Clinician Researcher in October 2019. He graduated from the Royal College of Surgeons in Ireland in 2004 and completed his PhD in Trinity College Dublin in 2016. He further completed a clinical fellowship in stroke neurology with the University of Toronto in 2017. His research interests include vascular causes of cognitive impairment, falls, orthostatic hypotension and syncope. He is a member of the Canadian Consortium on Neurodegeneration and Aging (CCNA) as well as the Cognitive Clinical Trials group within the division of Geriatric Medicine. Keywords: Cardiac disorders in older adults Falls and syncope Frailty Orthostatic Hypotension and Autonomic Dysfunction | |||
| Geriatric Medicine michael.borrie@sjhc.london.on.ca |
|||
 MICHAEL BORRIE, MD, FRCPC, Professor Dr. Michael Borrie is the Medical Director for the Aging Brain and Memory Clinic and is an investigator with the Cognitive Clinical Research Group. The group consists of investigators, clinical trials coordinators, clinicians and research assistants who do research in Neurodegenerative disorders. The group is based at Parkwood Institute and conducts investigator-initiated studies and pharmaceutical sponsored randomized controlled trials. As well, they provide education and clinical support to people with cognitive impairment and their families who are in the community. Dr. Borrie collaborates with Dr. Rob Bartha, Neuroimaging Scientist at the Robarts Research Institute, and his team of graduate students. These investigator-initiated neuroimaging studies have examined early markers of disease progression from Subjective Cognitive Decline to Mild Cognitive Impairment to Alzheimer Disease using magnetic resonance spectroscopy (MRS) and structural MRI at high magnetic field intensity. Dr. Borrie is the platform leader for the Canadian Collaboration on Neurodegeneration and Aging (CCNA), Compass-ND Study and is one of the 5 Canadian site investigators for the NIH funded North American Alzheimer Disease Neuroimaging Initiative (ADNI). The Cognitive Clinical Research Group conducts pharmaceutical company sponsored randomized controlled trials of investigational compounds with the potential for disease modification in participants with underlying Alzheimer’s Disease. The trials are recruiting participants who are cognitively normal or have subjective cognitive decline or amnestic mild cognitive impairment or mild dementia. Underlying predisposition to Alzheimer’s Disease is confirmed with amyloid Positron Emission Tomography (PET) Imaging, CSF analysis and blood biomarkers. Keywords: Alzheimer's disease Alzheimer's disease Disease Neuroimaging Initiative (ADNI) Biomarkers Canadian Collaboration on Neurodegeneration and Aging (CCNA) Magnetic Resonance Imaging/Spectroscopy Mild Cognitive Impairment Neuroimaging studies Randomized controlled trials | |||
| Geriatric Medicine Monidipa.Dasgupta@sjhc.london.on.ca |
|||
 MONIDIPA DASGUPTA, MD, FRCPC, Associate ProfessorDr. Dasgupta is an associate professor in the division of Geriatric Medicine at Western University. She practices in both the acute care and ambulatory settings at London Health Sciences Centre and Parkwood Institute. She is a consultant on the Acute Care for the Elderly (ACE) service, and the clinical lead for the geriatric consult-liaison service. Her clinical and research interests include delirium, hospital care for the elderly and non-pharmacologic approaches to managing behaviors in hospitalized seniors with cognitive disorders. She started a multi-disciplinary restraint reduction committee for the Acute Care for the Elderly service at London Health Sciences center and is actively involved in trying to decrease restraint use in the hospital. She and her team of geriatric nurse practitioners (the No Holds- Alternatives to Restraints for Respect, Mobility and Safety – No-HARRMS) were awarded the 2025 Patient Safety Champion award from the London Health Sciences Centre for their work on physical restraint reduction. Keywords: Acute care management of older adults Delirium Perioperative care of older adults | |||
| Geriatric Medicine George.Heckman@sjhc.london.on.ca |
|||
 GEORGE HECKMAN, MD, FRCPC, Associate ProfessorBio sketch and keywords unavailable. | |||
| Geriatric Medicine Manuel.MonteroOdasso@sjhc.london.on.ca |
|||
 MANUEL MONTERO ODASSO, MD, PhD, FRCPC, AGSF, FGSA, FCAHS, Professor Manuel Montero-Odasso, MD (University of Buenos Aires, Argentina), PhD, (University of Buenos Aires, Argentina), Postdoctoral Fellowship (McGill University, Canada), is currently a Professor in the Departments of Medicine, and Epidemiology and Biostatistics at Western University, and Director of the Gait and Brain Lab at Parkwood Institute. He is an internist, geriatrician, and clinician-scientist, and serves as team leader at the Canadian Consortium on Neurodegeneration in Aging (CCNA) and Director of the Brain Health Care Training Platform (BHCare). He also holds the inaugural Wolfe Research Professorship in Aging. Dr. Montero-Odasso leads the Gait and Brain Health Program, which aims to understand the mechanisms and potential treatments for mobility and cognitive decline in ageing. His research focuses on gait performance, and he has established the use of “motor biomarkers” such as gait slowing and dual-task gait to predict frailty, falls, and dementia. He has conducted clinical trials applying the novel approach of “improving cognition to improve mobility” using both pharmacological and non-pharmacological treatments, including physical exercise, cognitive training, and non-invasive brain stimulation. As team leader in CCNA (Canada Research Dementia Strategy), he focuses on multi-domain clinical trials, including the SYNERGIC Trials, which aim to delay dementia in older adults at risk (MCI spectrum) through interventions like physical exercise, cognitive training, dietary interventions (Vitamin D), sleep improvements, and control of cardiometabolic factors. He has built a successful research program while maintaining an active clinical practice. His research has received continuous peer-reviewed funding (> $16M) from national and international agencies, including the Canadian Institutes of Health and Research, Weston Brain Institute, and The Government of Ontario. He has published over three hundred peer-reviewed articles in high-impact journals in aging and neuroscience, including JAMA, JAMA Neurology and Open, Brain, Neurology, JGMS, and JAGS. Additionally, he has edited two books and eighteen chapters on topics related to aging, mild cognitive impairment, Alzheimer’s disease, and mobility and falls. Dr. Montero-Odasso has received numerous national and international accolades, including the American Geriatrics Society New Investigator Award, the Premier of Ontario Excellence Research Award, the Schulich Clinician Scientist Award, the CIHR Investigator Award, and recognition as one of the top ten Hispanic-Canadians for his contribution to Medicine and Science. He has delivered over 100 keynote addresses. His research impact is further demonstrated by his ranking in the prestigious Stanford University Report as one of the ‘Top 2% world scientists’. In 2024, he was inducted as a Fellow in the Canadian Academy of Health Sciences, one of the highest honours in Canadian Medicine. Keywords: Alzheimer's disease Balance Clinical trials Cognitive training Dementia Exercise Frailty Gait Gait disorder Geriatrics Magnetic Resonance Imaging/Spectroscopy Mild Cognitive Impairment Mobility Neuroimaging Osteoporosis Vitamin D | |||
| Geriatric Medicine Ameya.Patwardhan@sjhc.london.on.ca |
|||
 AMEYA PATWARDHAN, MD, FRCPC, Assistant ProfessorDr Patwardhan completed his residency training in Neurology at the National Institute of Mental Health and Neurosciences (NIMHANS) in Bengaluru, India, followed by a two-year fellowship in Cognitive and Movement Disorders at Sunnybrook Health Sciences Centre, University of Toronto, under the mentorship of Dr. Sandra Black and Dr. Mario Masellis. He then completed a fellowship in Dementia and Neurodegeneration at the University of Western Ontario. His clinical practice focuses on neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, Lewy body dementia, frontotemporal dementia, and normal pressure hydrocephalus (NPH). His research interests span cognitive neurology and movement disorders, with a particular focus on clinical trials in Alzheimer’s disease, integrating neuropsychological assessments with neuroimaging to explore brain–behavior relationships, and studying imaging and fluid biomarkers in dementia. His teaching focuses on developing innovative educational approaches for resident trainees and advancing fellowship training in neurogeriatrics. He is an investigator in the Cognitive Clinical Trials group at Parkwood Hospital. He joined the Division of Geriatric Medicine at the Schulich School of Medicine & Dentistry, Western University, as an Assistant Professor and holds a cross-appointment in the Division of Clinical Neurological Sciences. Keywords: Clinical trials Dementia Education and Neurodegenration Fellowship Curriculum Development Imaging and Fluid Biomarkers in dementia | |||
